Session E: Models of care to enhance engagement in care
Tracks
Track 3
Wednesday, September 11, 2019 |
2:00 PM - 3:20 PM |
Fortifications, Level 9 |
Speaker
Mrs Mim O'Flynn
Outreach Fibroscan Nurse
Hepatitis Queensland
The Kombi Clinic – It’s the end of the road for Hepatitis C
2:00 PM - 2:15 PMBiography
Dr Joss O'Loan is a GP (primary care physician) working in Brisbane Australia. Together with his mate and colleague Dr Matt Young, he started up the Kombi Clinic in an effort to screen, treat and cure those patients that aren’t engaging with the traditional models of care.
Dr Su Su Aung
Medical Coordinator
Asian Harm Reduction Network Myanmar
Effective DAA HCV Treatment and Care Model Among People Who Inject Drugs in Most Hard-to-Reach Conflict Areas in Northern Myanmar
2:15 PM - 2:30 PMBiography
A public health professional working in harm reduction project of Asian Harm Reduction Network (AHRN), delivering comprehensive health services for the people who use drugs in most hard-to-reach areas in northern Myanmar. Also the first medical doctor for a pioneer project in management of Hepatitis C infection among PWID.
Dr Jorge Valencia
Medical Coordinator
Hospital Universitario Infanta Leonor
Addressing the HCV cascade of care in vulnerable populations with poor access to healthcare in Madrid through of a point of care in a one step
2:30 PM - 2:45 PMBiography
He is a doctor and researcher in infectious diseases and currently he is a PhD student at the Alcala de Henares University (Madrid).He works in a Harm Reduction Unit of the Addiction Institute (Madrid) and is involved in research regarding viral infections(treatment, care and prevention) in people who injected drugs.
Ms Yumi Sheehan
Project Officer/Coordinator
The Kirby Institute/National Prisons Hepatitis Network
National Prisons Hepatitis Network - Facilitating enhanced infrastructure and scale-up of HCV treatment in Australian prisons: towards national elimination
2:45 PM - 2:50 PMBiography
Yumi is the coordinator for the National Prisons Hepatitis Network and project officer in the Viral Immunology Systems Program at The Kirby Institute, UNSW Sydney, where she coordinates the PIVOT study and the National Prisons Hepatitis Education Project. Yumi's main areas of research interest focus on scale-up of hepatitis C testing and treatment in Australian prisons
Ms Wangari Kimemia
Advocacy Officer
MDM
POLICE ARE RESPONSIVE TO HEPATITIS C PREVENTION: POLICE SENSITIZATION WITH A HEPATITIS C ENTRY HAVE PROVEN TO BE MORE EFFECTIVE IN NAIROBI, KENYA
2:50 PM - 2:55 PMBiography
Advocacy Officer at Medecins du Monde Harm Reduction Program in Nairobi Kenya for 1 year. Training Officer with MdM Kenya for 3 years, Formerly lecturer and teacher. Holds Bachelor of Education (English and Literature) , Masters of Arts (Sociology) and Currently pursuing Doctor of Philosophy in Sociology.
Ms Rachel Silk
Director, Clinical Research Operations
University Of Maryland
Establishing an Integrated Care Clinic for HCV-infected People Who Actively Inject Drugs (PWID) at a Harm Reduction Center in Washington, DC (ANCHOR Model)
2:55 PM - 3:00 PMBiography
Ms. Silk has 15 years nursing experience and has spent the last 10 years doing clinical research focused on HCV, co-infection with HV and more recently the intersection of infectious diseases and opioid-use disorder. She is the Program Manager for the DC Partnership for HIV/AIDS Progress Hepatitis Clinical Research Program.
Prof. George Kamkamidze
Head of Research Department
Health Research Union
HEPATITIS C TREATMENT INTEGRATION WITH HARM REDUCTION SERVICES IN GEORGIA: PRELIMINARY FINDINGS
3:00 PM - 3:05 PMBiography
George Kamkamidze is a medical doctor practicing in immunology and infectious diseases. He received PhD in immunology and was post-doctoral fellow in molecular virology at Wadsworth center, NY. His research is mostly focused on viral hepatitis and HIV in different risk groups, including PWID. Dr. Kamkamidze is professor of epidemiology and biostatistics at Georgian-American University and director of clinic NeoLab, providing HCV treatment services, including to PWID.
Dra Cláudia Pereira
Research and Development Manager
Ares do Pinhal – Non Governmental Organization for Social Inclusion
GOOD PRACTICES IN HEALTH RESPONSE TO HCV IN A HARM REDUCTION PROGRAM
3:05 PM - 3:10 PMBiography
Claudia Pereira has a degree in Psychology, with specialization in Criminal and Forensics Psychology. Claudia has about 20 years of experience in working in harm reduction. She is also the current research coordinator at the Mobile Methadone Low Threshold Outreach Program in Lisbon.
Mr Timmy Lockwood
Clinical Nurse Consultant
NSW STIPU
PARTNERING WITH CONSUMERS: THE DEVELOPMENT OF A PRIMARY HEALTH CARE HEPATITIS C TREATMENT MODEL WITHIN A PEER-BASED NEEDLE AND SYRINGE PROGRAM.
3:10 PM - 3:15 PMBiography
Timmy Lockwood is a clinical nurse consultant at the Kirketon Road Centre in Sydney, Australia. KRC is involved in the prevention, treatment and care of viral hepatitis among people who inject drugs.
Ms. Jane Crowe
Hepatitis C Program Manager
Knox County Health Department
A COMMUNITY-BASED APPROACH TO VIRAL HEPATITIS IN CENTRAL APPALACHIA
3:15 PM - 3:20 PMBiography
Ms. Crowe received a Masters in Social Work from UT Knoxville. Since 2016, she has served as Manager for Knox County Health Department Hepatitis C Program. Ms. Crowe's career includes counseling/case management in domestic violence, reproductive health, and HIV/AIDS. She also has experience in nonprofit fundraising and program development.
Chair
Marie-ève Goyer
Médecin Chef De Service En Itinérance Et Médecine De Proximité
Ciusss Ccsmtl
Martin Kåberg
Medical Supervisor for the Stockholm Needle Exchange Programs
Stockholm Centre for Dependency Disorders